Are There Any Clinical Trials Involving MRP Inhibitors?
Yes, there are ongoing clinical trials investigating MRP inhibitors. For instance, inhibitors like Reversan and MK-571 have been evaluated for their ability to sensitize cancer cells to chemotherapy. While some studies have shown promise, the clinical utility of MRP inhibitors remains an area of active research.